Krka Out Of The Blocks Solidly In Q1, With Russia Still Largest Market
Slovenian Firm ‘Second Largest Foreign Provider Of Generic Medicines’ In Russia
Krka has reaffirmed its full-year financial goals after a solid start to 2024, which included 8% revenue growth for its pharmaceutical products. Generics Bulletin examines the company’s sprawling global operations.
